VC-backed Profound Medical to go public, raises $28 mln in new funding
Profound Medical Inc has launched a going-public transaction via a reverse take-over of Mira IV Acquisition Corp (TSXV: MRY.P), which trades on the TSX Venture Exchange. The company has also completed a private placement for gross proceeds of about $24 million. Two long-time venture capital investors in Profound Medical, Genesys Capital and BDC Capital, joined the offering and provided bridge financing. Strategic investor Knight Therapeutics Inc also joined the offering and extended a $4 million secured loan. The Toronto-based Profound Medical, which was founded in 2008, is a medical device business focused on developing and commercializing a minimally invasive treatment for prostate cancer.
1 May 2015•6 mins read
